JQJingqian Qin

Jingqian Qin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jingqian Qin has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Liang

    Department of Gastroenterology, Minzu Hospital of Guangxi Medical University, Nanning, China

    1 shared publication
  • Fenghua Mb Ai

    Department of Nutrition, The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning, Guangxi, China

    1 shared publication
  • Mengjie Mb Qin

    Department of Nutrition, The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning, Guangxi, China

    1 shared publication
  • Shuang Mb Liu

    Department of Nutrition, The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning, Guangxi, China

    1 shared publication
  • Tao Jiang

    Department of Nutrition, The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning, Guangxi, China

    1 shared publication
  • Xiying Zhou

    Department of Obstetrics, Guangxi Academy of Medical Sciences, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China

    1 shared publication

Latest Publications

  • Open Access

    Systemic inflammatory biomarkers and their partial role in the association between diabetes and sarcopenia: A population-based study using NHANES data

    by Jingqian Qin, Xue Qiu, Bin Liang, Yongyu Chen, Tao Jiang

    The mediating role of inflammatory biomarkers in the association between diabetes and sarcopenia remains poorly quantified in general populations. This study aims to investigate this relationship and quantify the mediating effects of systemic inflammatory indicators. This cross-sectional study included 11,190 adults from the National Health and Nutrition Examination Survey 2011 to 2018. Weighted logistic regression and subgroup analyses were used to assess the association between diabetes and sarcopenia, defined by the Foundation for the National Institutes of Health criteria (appendicular skeletal muscle mass/body mass index). Mediation analysis with bootstrapping was performed to evaluate the mediating roles of white blood cells, neutrophils, lymphocytes, neutrophil-to-lymphocyte ratio, and Systemic Immune-Inflammation Index. Diabetes was significantly associated with an increased risk of sarcopenia (odds ratio = 1.48, 95% confidence interval: 1.03–2.13, P = .042) after full adjustment. Mediation analysis revealed that white blood cells, neutrophils, lymphocytes, neutrophil-to-lymphocyte ratio, and Systemic Immune-Inflammation Index mediated 28.48%, 26.58%, 7.36%, 6.54%, and 10.17% of this association, respectively (all P < .05). Diabetes is positively associated with sarcopenia risk, partially mediated by systemic inflammation. Readily available inflammatory biomarkers may aid in identifying high-risk diabetic patients for sarcopenia prevention.

  • Open Access

    Association of dietary fiber sources with liver fibrosis assessed by transient elastography in U.S. adults: a cross-sectional study from NHANES 2017 to 2020

    by Shuang Mb Liu, Mengjie Mb Qin, Xiying Zhou, Fenghua Mb Ai, Jingqian Qin

    Dietary fiber intake is linked to metabolic health, yet its association with liver fibrosis, particularly across different fiber sources, remains incompletely understood. This study aims to assess the relationship between dietary fiber from various sources and liver fibrosis in Unites States National Health And Nutrition Examination Survey adults. We used data from National Health and Nutrition Examination Survey 2017 to 2020, examining the associations between dietary fiber intake and liver fibrosis assessed by transient elastography in a nationally representative sample of United States adults. Dietary fiber intake, including total fiber and fiber from fruits, vegetables, grains, and legumes, was assessed using 24-hour dietary recalls. Liver fibrosis was evaluated using both continuous liver stiffness measurements and a categorical definition of significant fibrosis (median liver stiffness ≥ 8 kPa). Survey-weighted linear and logistic regression models were applied, adjusting for sociodemographic characteristics, lifestyle behaviors, metabolic comorbidities, and total energy intake. After multivariable adjustment, higher intake of fruit-derived dietary fiber was consistently associated with lower liver stiffness ( β = −0.13, 95% confidence interval: −0.22 to −0.04). Compared with the lowest quartile, participants in the highest quartile of fruit fiber intake had significantly lower odds of significant liver fibrosis (odds ratio = 0.61, 95% confidence interval: 0.45–0.83). In contrast, total dietary fiber and fiber from vegetables, grains, and legumes showed weaker or less consistent associations, and no clear monotonic dose-response relationships were observed. These findings suggest that the source of dietary fiber, particularly fruit-derived fiber, may be more relevant than total fiber intake alone in relation to liver fibrosis risk. This study emphasizes the clinical importance of fiber sources in liver fibrosis management and supports further prospective studies to clarify causality.